Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "vaccines" return 126 results.
The Minister for Agriculture and Food visits the Ceva Santé Animale plant in China >
Marc Prikazsky, Chairman of Ceva, welcomes the Minister of Agriculture and Food and his delegation to the company's Beijing plant.
Ceva details latest poultry “Vaccinology” approach claiming simple vaccination is no longer enough >
At WVPA Congress, Edinburgh, the company outlines its latest innovations, in vaccines, equipment, services and quality certification
Animal Welfare a major focus as the World’s veterinarians meet in Korea >
The World Veterinary Association (WVA) with Ceva Santé Animale (Ceva) recognize 6 outstanding veterinarians for their commitment to promoting the welfare of Animals
Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan >
7,8 billion forint (€ 25m) investment will significantly increase production at its Budapest Campus
Ceva announces important advances in the control of respiratory disease in poultry >
Ceva Vaccination Summit details new claims for IB Vaccines.
Ceva shines light on the future with focus on innovation during VIV Asia 2017 >
Ceva’s teams brought innovation to the fore during VIV Asia 2017
Ceva reinforces its position in China and swine through new joint-venture with EBVAC >
In the presence of the Chinese Prime Minister, Li Keqiang and French Prime Minister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVAC today signed a joint-venture agreement to create a new busin...
Ceva Santé Animale confirms its circle of virtuous growth in 2016 >
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m as the Ceva Group continued to achieve double-digit growth, cementing its position as the 6th. larg...
Ceva stresses the need for continued innovation to ensure effective disease control at IPPE 2017 >
Vectormune® ND, vaccine for Newcastle Disease (ND) Cevac IBird®, for Infectious Bronchitis (IB) prevention will continue to lead offerings for effective and easily administered disease control.
Ceva completes deal to acquire portfolio of Merial swine & cattle vaccines and nonsteroidal anti-inflammatories from Boehringer Ingelheim >
19 January 2017: Ceva Santé Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from...